Pimagedine inhibitor of advanced glycosylation end products data

ALTN reported positive Phase II findings with the inhibitor of abnormal glucose/protein complexes that lead to diabetic complications. In

Read the full 198 word article

How to gain access

Continue reading with a
two-week free trial.